2013 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Research and Markets (http://www.researchandmarkets.com/research/7x3q48/global_infectious) has announced the addition of the "Global Infectious Diseases Drug Pipeline Capsule - 2013" report to their offering (see also Research and Markets).
The latest report Global Infectious Diseases Drug Pipeline Capsule - 2013' provides up-to-date information on key research and development activities in the global infectious diseases drug market. It covers active pipeline molecules under development in various stages of clinical trials, preclinical research, and drug discovery for Hepatitis, HIV, Influenza, Small Pox, Malaria, Tuberculosis, Tetanus, Herpes Simplex, and Human Papillomavirus.
This report helps executives track their competitor's pipeline molecules. The information presented in this report can be used for identifying partners, evaluating business opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company, mechanism of action, stage (phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and drug discovery), and geography (North America, Europe, and Asia).
Keywords for this news article include: HIV/AIDS, RNA Viruses, Retroviridae, Tuberculosis, HIV Infections, Pre-Trial Research, Vertebrate Viruses, Infectious Diseases, Human Papillomavirus, Primate Lentiviruses, Research and Markets, Opportunistic Infections, Clinical Trials and Studies, Viral Sexually Transmitted Diseases.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC